Reduce tremor and improve movement
- Trial ID
- NCT06400017
- Official Title
- Mechanism and Application of Deep Brain Stimulation in the Treatment of Parkinson's Disease
- Goal
- Reduce tremor and improve movement
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Beijing Tiantan Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson's Disease and Parkinsonism
- Interventions
- microelectrode stimulation of DBS
Summary For Families
The trial aims to clarify how deep brain stimulation of the subthalamic nucleus controls Parkinson's motor symptoms and to evaluate the mechanism and application of an MRI-compatible dual-channel DBS system. It uses microelectrode-guided bilateral STN DBS with a 3.0T-compatible G106R/G106RS device, delivering continuous electrical pulses to rebalance abnormal motor circuits, which can reduce tremor, rigidity, and slowness and often lets people lower their levodopa dose. Participants should be adults 50 to 70 years old with typical Parkinson's for less than 20 years who plan bilateral STN DBS, have no major cognitive impairment (MMSE ≥24, MoCA ≥18), and have no medical or MRI contraindications to surgery.
Locations
- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying microelectrode stimulation of DBS. The trial aims to clarify how deep brain stimulation of the subthalamic nucleus controls Parkinson's motor symptoms and to evaluate the mechanism and application of an MRI-compatible dual-channel DBS system. It uses microelectrode-guided bilateral STN DBS with a 3.0T-compatible G106R/G106RS device, delivering continuous electrical pulses to rebalance abnormal motor circuits, which can reduce tremor, rigidity, and slowness and often lets people lower their levodopa dose. Participants should be adults 50 to 70 years old with typical Parkinson's for less than 20 years who plan bilateral STN DBS, have no major cognitive impairment (MMSE ≥24, MoCA ≥18), and have no medical or MRI contraindications to surgery.
- Who can participate?
- Participants must be between 50 Years and 70 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 6 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.